MedImmune LLC
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1987-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://medimmune.com
A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2014-03-21
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 11
- Registration Number
- NCT00590720
- Locations
- 🇨🇦
UHN- Toronto Western Hospital, Toronto, Ontario, Canada
🇺🇸Northeast Medical Research Associates, Inc, No. Dartmouth, Massachusetts, United States
🇺🇸Institute of Healthcare Assessment, Inc, San Diego, California, United States
A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia
- First Posted Date
- 2008-01-07
- Last Posted Date
- 2017-07-06
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 11
- Registration Number
- NCT00587457
- Locations
- 🇵🇱
Research Site, Lodz, Poland
A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia
- Conditions
- Interventions
- First Posted Date
- 2008-01-07
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 49
- Registration Number
- NCT00586924
- Locations
- 🇵🇱
Research Site, Lodz, Poland
A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)
- First Posted Date
- 2008-01-07
- Last Posted Date
- 2011-11-22
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 50
- Registration Number
- NCT00587015
- Locations
- 🇺🇸
Tower Hematology Oncology Medical Group, Beverly Hills, California, United States
🇵🇱Kalinika Hemotologii Uniwersytetu Medycznego, Lodz, Poland
🇺🇸NCI, National Institutes of Health, Bethesda, Maryland, United States
A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2011-11-23
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 31
- Registration Number
- NCT00578682
- Locations
- 🇺🇸
Covance Daytona Beach, Daytona Beach, Florida, United States
A Post Marking Study to Evaluate the Safety of FluMist in Children
- Conditions
- Interventions
- First Posted Date
- 2007-12-10
- Last Posted Date
- 2012-03-08
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 29296
- Registration Number
- NCT00569894
- Locations
- 🇺🇸
Research Site, Oakland, California, United States
A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis
- First Posted Date
- 2007-10-08
- Last Posted Date
- 2007-11-28
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 420
- Registration Number
- NCT00540618
- Locations
- 🇺🇸
The South Bend Clinic, South Bend, Indiana, United States
🇺🇸nTouch Research Corporation, San Diego, California, United States
🇺🇸Northwestern University Medical School, Chicago, Illinois, United States
A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease
- Conditions
- Interventions
- First Posted Date
- 2007-10-03
- Last Posted Date
- 2012-02-16
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 1236
- Registration Number
- NCT00538785
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸Washington University School of Medicine, St. Louis, Missouri, United States
A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma
- First Posted Date
- 2007-10-02
- Last Posted Date
- 2008-09-05
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 18
- Registration Number
- NCT00538096
A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis
- Conditions
- Interventions
- First Posted Date
- 2007-09-21
- Last Posted Date
- 2012-05-28
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 51
- Registration Number
- NCT00533091
- Locations
- 🇺🇸
Research Site, Duncansville, Pennsylvania, United States